US Economic, Social Cost of Advanced Parkinson’s in Billions, Study Says

US Economic, Social Cost of Advanced Parkinson’s in Billions, Study Says

294547

US Economic, Social Cost of Advanced Parkinson’s in Billions, Study Says

Limitations in functional abilities due to advanced Parkinson’s disease result in billions of dollars of lost economic value in the U.S., but effective treatments that restore some essential abilities can lessen this lost value, a study reports. Levodopa-carbidopa intestinal gel, sold in the U.S. under the brand name Duopa and as Duodopa in the EU and elsewhere, was the particular treatment noted in this study. The work was funded by AbbVie, which developed and markets this therapy.…

You must be logged in to read/download the full post.